Compounds > n(6)-carboxymethyllysine
Page last updated: 2024-09-03

n(6)-carboxymethyllysine and pyridoxamine

n(6)-carboxymethyllysine has been researched along with pyridoxamine in 6 studies

Compound Research Comparison

Studies
(n(6)-carboxymethyllysine)		Trials
(n(6)-carboxymethyllysine)		Recent Studies (post-2010)
(n(6)-carboxymethyllysine)		Studies
(pyridoxamine)		Trials
(pyridoxamine)		Recent Studies (post-2010) (pyridoxamine)
803443656729146

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alderson, NL; Anderson, NL; Baynes, JW; Boyle, C; Canning, P; Chachich, M; Duffy, N; Frizzell, N; Gardiner, TA; Januszewski, AS; Stitt, A; Thorpe, SR1
Culbertson, SM; Ingold, KU; Morrison, LD; Vassilenko, EI1
Hudson, BG; Jacob, J; Khalifah, RG; Serianni, AS; Thibaudeau, C; Voziyan, PA; Yildiz, A1
Aoki, T; Gohda, T; Hagiwara, S; Horikoshi, S; Ito, T; Kaneko, S; Matsumoto, M; Murakoshi, M; Tanimoto, M; Tomino, Y; Yamada, K1
Bloemen, JG; Buurman, WA; Dejong, CH; Driessen, A; Gaens, KH; Greve, JW; Hofker, MH; Niessen, PM; Rensen, SS; Schalkwijk, CG; Stehouwer, CD; Wolfs, MG1
Bidasee, KR; Kutty, S; Moore, CJ; Nagai, R; Shao, CH; Singh, J1

Other Studies

6 other study(ies) available for n(6)-carboxymethyllysine and pyridoxamine

ArticleYear
The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.
    Diabetes, 2002, Volume: 51, Issue:9

    Topics: Animals; Capillaries; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Extracellular Matrix; Female; Glycation End Products, Advanced; Laminin; Lysine; Pyridoxamine; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels; RNA, Messenger

2002
Paradoxical impact of antioxidants on post-Amadori glycoxidation: Counterintuitive increase in the yields of pentosidine and Nepsilon-carboxymethyllysine using a novel multifunctional pyridoxamine derivative.
    The Journal of biological chemistry, 2003, Oct-03, Volume: 278, Issue:40

    Topics: Antioxidants; Arginine; Biochemistry; Chromatography, High Pressure Liquid; Cross-Linking Reagents; Dose-Response Relationship, Drug; Gas Chromatography-Mass Spectrometry; Glucose; Glycation End Products, Advanced; Ions; Lysine; Models, Chemical; Pyridoxamine; Ribose; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors

2003
Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions.
    The Journal of biological chemistry, 2003, Nov-21, Volume: 278, Issue:47

    Topics: Animals; Carbon Isotopes; Diabetes Mellitus; Glucose; Glycation End Products, Advanced; Humans; Lysine; Metals; Nuclear Magnetic Resonance, Biomolecular; Oxidation-Reduction; Protein Processing, Post-Translational; Proteins; Pyridoxamine

2003
Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice.
    Metabolism: clinical and experimental, 2007, Volume: 56, Issue:2

    Topics: Animals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glycation End Products, Advanced; Immunohistochemistry; Laminin; Lysine; Male; Mice; Pyridoxamine; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schiff Bases; Transforming Growth Factor beta1; Tyrosine

2007
Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis.
    Journal of hepatology, 2012, Volume: 56, Issue:3

    Topics: Aged; Biomarkers; Biopsy; Cytokines; Enzyme Inhibitors; Fatty Liver; Female; Gene Expression; Guanidines; Hep G2 Cells; Hepatocytes; Humans; In Vitro Techniques; Liver; Lysine; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Pyridoxamine; Vitamin B Complex

2012
Malondialdehyde and 4-hydroxynonenal adducts are not formed on cardiac ryanodine receptor (RyR2) and sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) in diabetes.
    Molecular and cellular biochemistry, 2013, Volume: 376, Issue:1-2

    Topics: Aldehydes; Animals; Arginine; Calcium; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Echocardiography; Guanidines; Lysine; Male; Malondialdehyde; Myocytes, Cardiac; Norleucine; Protein Carbonylation; Pyridoxamine; Pyrroles; Rats; Rats, Sprague-Dawley; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Spin Labels

2013